Brief: Biomerieux Confirmation Of The 2023 Guidance
Oct 26 (Reuters) - Biomerieux SA BIOX.PA :
* BIOMÉRIEUX – THIRD-QUARTER 2023 BUSINESS REVIEW
* +8.0% SALES ORGANIC GROWTH OVER THE FIRST NINE MONTHS OF
THE
YEAR
* Q3 SALES ORGANIC GROWTH AT +7.1% (+10.3% EXCLUDING
BIOFIRE®
RESPIRATORY PANELS), ON PAR WITH EXPECTATIONS
* CONFIRMATION OF THE 2023 GUIDANCE
Source text for Eikon: ID:nNDL2z9BQs
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biomerieux SA
See all newsFactbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development
Factbox: What Bundibugyo Ebola vaccines and treatments are under development